Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

US STOCKS-Wall St ends up slightly in late rally led by banks

Published 07/27/2009, 05:08 PM
Updated 07/27/2009, 05:16 PM
AMGN
-
VZ
-

* New home sales post biggest monthly gain in eight years * Home builders, banks up after home sales data * Amgen profit beats view, shares up after the bell * Dow up 0.2 pct; S&P up 0.3 pct; Nasdaq up 0.1 pct (Updates to add Amgen after results, volume)

By Rodrigo Campos

NEW YORK, July 27 (Reuters) - U.S. stocks rose slightly on Monday in a late rally as investors rotated into financial shares, which had lagged in the recent two-week run-up.

Upbeat data on new home sales underpinned financial stocks, the session's strongest sector, and prompted investors to snap up the shares of several regional banks, which had been among the worst hit by credit losses tied to a weak housing market.

Regions Financial Corp jumped 8.9 percent to $4.02 on the New York Stock Exchange and Zions Bancorporation soared 13 percent to $12.65 on the Nasdaq, while the KBW Bank Index rose 3.1 percent.

Financials had lagged in the previous weeks, but Friday saw the beginning of a rotation into the sector and out of technology, which continued Monday, according to Michael James, senior trader at Wedbush Morgan in Los Angeles.

The Dow Jones U.S. home construction index shot up 4.3 percent after data showed U.S. new home sales posted their biggest monthly gain in eight years in June, suggesting the housing market may be starting to recover from its worst slump since the Great Depression of the 1930s.

Stronger-than-expected earnings, coupled with upbeat economic data, have lifted indexes recently, giving stocks their best two-week run since just after the S&P 500 hit a 12-year closing low in the beginning of March. The three major indexes rose about 11 percent each over the past two weeks.

The Dow Jones industrial average rose 15.27 points, or 0.17 percent, to close at 9,108.51. The Standard & Poor's 500 Index gained 2.92 points, or 0.30 percent, to 982.18. The Nasdaq Composite Index added 1.93 points, or 0.10 percent, to end at 1,967.89.

"There was a little more willingness to bid stocks up two weeks ago on positive earnings surprises," said Wedbush Morgan's Michael James. "You're seeing people less willing to do that now, given the move the market has had in the last two weeks."

Shares of Dow component Verizon Communications fell 1.6 percent to $31 after the company reported second-quarter earnings that fell from a year ago.

Aetna shares shed 2.7 percent to $25.72 after the company, one of the biggest U.S. providers of employer-based health insurance, cut its full-year outlook, citing higher-than-projected medical costs.

AMGEN JUMPS AFTER THE BELL

After the closing bell, shares of Amgen Inc rose 3.2 percent to $62.72 as the biotechnology company raised its full-year earnings forecast and reported a better-than-expected quarterly profit. Amgen said its results were helped by strong sales of its rheumatoid arthritis drug and a tax benefit. The stock closed on Nasdaq at $60.77, down 0.25 percent, or 15 cents, before the release of the results.

In the regular session, volume was light on the New York Stock Exchange, where about 1.04 billion shares changed hands, less than last year's estimated daily average of 1.49 billion. On the Nasdaq, about 2.16 billion shares traded, below last year's daily average of 2.28 billion.

Advancers outnumbered decliners on the NYSE by a ratio of 9 to 5, while on the Nasdaq, about 13 stocks rose for every 10 that fell. (Editing by Jan Paschal)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.